| Closed |
SWOG-9132 |
Evaluation of Alpha Interferon/Isotretinoin or Alpha Interferon/All Trans Retinoic Acid in Cervical Cancer, Phase II |
9/15/1992 |
5/15/1996 |
100% |
|
Published
|
| Closed |
SWOG-8717 |
Evaluation of Amonafide and Didemnin-B in the Treatment of Ovarian Cancer |
5/15/1988 |
|
63% |
|
Published
|
| Closed |
SWOG-8722 |
Evaluation of Amonafide in Adenocarcinoma of the Prostate |
11/1/1987 |
4/1/1989 |
|
|
Published
|
| Closed |
SWOG-8715 |
Evaluation of Amonafide in Advanced Sarcomas |
3/1/1988 |
2/1/1990 |
|
|
Published
|
| Closed |
SWOG-8725 |
Evaluation of Amonafide in Cervical Cancer |
12/1/1988 |
12/1/1990 |
|
|
Published
|
| Closed |
SWOG-8714 |
Evaluation of Amonafide in Colorectal Carcinoma |
3/1/1988 |
5/1/1989 |
|
|
Published
|
| Closed |
SWOG-8723 |
Evaluation of Amonafide in Disseminated Malignant Melanoma |
7/15/1988 |
6/1/1990 |
|
|
Published
|
| Closed |
SWOG-8732 |
Evaluation of Amonafide in Endometrial Carcinoma |
3/1/1988 |
3/1/1991 |
100% |
|
Published
|
| Closed |
SWOG-8730 |
Evaluation of Amonafide in Esophageal Cancer |
11/1/1990 |
4/15/1992 |
46% |
|
Published
|
| Closed |
SWOG-8720 |
Evaluation of Amonafide in Pancreatic Adenocarcinoma |
7/1/1988 |
7/15/1990 |
100% |
|
Published
|
| Closed |
SWOG-8726 |
Evaluation of Amonafide in Refractory Multiple Myeloma |
4/1/1988 |
11/1/1989 |
57% |
|
Published
|
| Closed |
SWOG-8716 |
Evaluation of Amonafide in Renal Cell Carcinoma |
11/1/1987 |
11/15/1988 |
|
|
Published
|
| Closed |
SWOG-8829 |
Evaluation of Amonafide in the Treatment of CNS Tumors |
3/15/1989 |
12/1/1990 |
97% |
|
Published
|
| Closed |
SWOG-8063 |
Evaluation of Anguidine (NSC-141537) in Refractory Adult Acute Nonlymphocytic Leukemia |
4/22/1980 |
4/14/1981 |
|
|
|
| Closed |
SWOG-7736 |
Evaluation of Anguidine in the Treatment of Urological Malignancies |
12/29/1977 |
3/15/1979 |
|
|
|
| Closed |
SWOG-8400/05 |
Evaluation of AT-125 and Fludarabine Phosphate in Central Nervous System Tumors |
12/7/1984 |
1/15/1987 |
|
|
Published
|
| Closed |
SWOG-8310 |
Evaluation of Aziridinylbenzoquinone (AZQ) (NSC-182986) in Refractory and Relapsing Myeloma |
12/7/1984 |
11/1/1986 |
|
|
Published
|
| Closed |
SWOG-8233 |
Evaluation of Aziridinylbenzoquinone (AZQ) in Gastric Carcinoma |
10/18/1983 |
12/1/1986 |
|
|
|
| Closed |
SWOG-8106 |
Evaluation of AZQ (Carbamic Acid) in Central Nervous System Tumors |
11/30/1981 |
1/31/1983 |
|
|
Published
|
| Closed |
SWOG-8044 |
Evaluation of AZQ in Pancreatic Carcinoma TEMPORARILY CLOSED: 8/17/84 |
10/29/1982 |
3/22/1985 |
|
|
Published
|
